vimarsana.com

Latest Breaking News On - Medical practice income - Page 1 : vimarsana.com

USA Equities Corp (USAQ) and AllergiEnd Announces Allergy Testing Kit Distribution ahead of COVID-19 Vaccine

Share: West Palm Beach, FL, Dec. 10, 2020 (GLOBE NEWSWIRE) While the recent and rapid development of Pfizer/BioNTech s COVID-19 vaccine is undoubtedly good news, Time Magazine reported that administering this vaccine to individuals with a history of severe allergic reactions is not recommended, according to a U.K. Regulator, as the United Kingdom is the first country to begin vaccinations. This news comes after two healthcare professionals, both with a history of anaphylactoid reactions, suffered adverse side effects to the vaccine. They have since recovered. As the United States waits for the vaccine, this news from the U.K. is a cautionary warning. Physicians should begin making preparations ahead of time for those patients with a history of allergic reactions. Despite the uncertainty surrounding this vaccine, physicians can alleviate the patient s worry by providing an allergy test ahead of vaccination. Patients should explore allergy testing ahead of vaccination. Often some

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.